Mach7 Technologies

Enterprise Imaging Expansion And AI Adoption Will Drive Powerful Long Term Upside Potential

AnalystHighTarget

Not Invested

Community Contributor

Published

19 Dec 25

Views

n/a

AnalystHighTarget's Fair Value

n/a

71.2%

-2.6%

71.2%

-2.6%

You can edit this narrative until Dec 20 12:04 PM. Then, changes will post as Updates.

Author's Valuation

AU$0.829.4% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

AU$0.8

29.4% undervalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

10.78%

Healthtech revenue growth rate

12.65%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.25%

Calculation

AU$9.08m

Earnings '28

24.27x

PE Ratio '28

AU$220.36m

Market Cap '28

AU$220.36m

Market Cap '28

217.11m

No. shares '28

AU$1.01

Share Price '28

AU$1.01 Share Price '28

Discounted to 2025 @ 8.26% p.a.

AU$0.80

Fair Value '25